Mostrar el registro sencillo del ítem

dc.rights.licenseopenen_US
dc.contributor.authorCOSTAS-INSUA, Carlos
dc.contributor.authorHERMOSO-LÓPEZ, Alba
dc.contributor.authorMORENO, Estefanía
dc.contributor.authorMONTERO-FERNÁNDEZ, Carlos
dc.contributor.authorÁLVARO-BLÁZQUEZ, Alicia
dc.contributor.authorMAROTO, Irene B
dc.contributor.authorSÁNCHEZ-RUIZ, Andrea
dc.contributor.authorDIEZ-ALARCIA, Rebeca
dc.contributor.authorBLÁZQUEZ, Cristina
dc.contributor.authorMORALES, Paula
dc.contributor.authorCANELA, Enric I
dc.contributor.authorCASADÓ, Vicent
dc.contributor.authorURIGÜEN, Leyre
dc.contributor.authorPEREA, Gertrudis
hal.structure.identifierNeurocentre Magendie : Physiopathologie de la Plasticité Neuronale [U1215 Inserm - UB]
dc.contributor.authorBELLOCCHIO, Luigi
dc.contributor.authorRODRÍGUEZ-CRESPO, Ignacio
dc.contributor.authorGUZMÁN, Manuel
dc.date.accessioned2025-05-30T13:36:26Z
dc.date.available2025-05-30T13:36:26Z
dc.date.issued2024-04
dc.identifier.issn1757-4676en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/206793
dc.description.abstractEnCereblon/CRBN is a substrate-recognition component of the Cullin4A-DDB1-Roc1 E3 ubiquitin ligase complex. Destabilizing mutations in the human CRBN gene cause a form of autosomal recessive non-syndromic intellectual disability (ARNSID) that is modelled by knocking-out the mouse Crbn gene. A reduction in excitatory neurotransmission has been proposed as an underlying mechanism of the disease. However, the precise factors eliciting this impairment remain mostly unknown. Here we report that CRBN molecules selectively located on glutamatergic neurons are necessary for proper memory function. Combining various in vivo approaches, we show that the cannabinoid CB1 receptor (CB1R), a key suppressor of synaptic transmission, is overactivated in CRBN deficiency-linked ARNSID mouse models, and that the memory deficits observed in these animals can be rescued by acute CB1R-selective pharmacological antagonism. Molecular studies demonstrated that CRBN interacts physically with CB1R and impairs the CB1R-Gi/o-cAMP-PKA pathway in a ubiquitin ligase-independent manner. Taken together, these findings unveil that CB1R overactivation is a driving mechanism of CRBN deficiency-linked ARNSID and anticipate that the antagonism of CB1R could constitute a new therapy for this orphan disease. © The Author(s) 2024.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enCannabinoid
dc.subject.enCereblon
dc.subject.enHippocampus
dc.subject.enMemory
dc.subject.enRimonabant
dc.title.enThe CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls
dc.title.alternativeEMBO Mol Meden_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1038/s44321-024-00054-wen_US
dc.subject.halSciences du Vivant [q-bio]/Neurosciences [q-bio.NC]en_US
dc.identifier.pubmed38514794en_US
bordeaux.journalEMBO Molecular Medicineen_US
bordeaux.page755 – 783en_US
bordeaux.volume16en_US
bordeaux.hal.laboratoriesNeurocentre Magendie - U1215en_US
bordeaux.issue4en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamEndocannabinoïdes et Neuroadaptationen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-05090813
hal.version1
hal.date.transferred2025-05-30T13:36:33Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
dc.rights.ccCC BYen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=EMBO%20Molecular%20Medicine&rft.date=2024-04&rft.volume=16&rft.issue=4&rft.spage=755%20%E2%80%93%20783&rft.epage=755%20%E2%80%93%20783&rft.eissn=1757-4676&rft.issn=1757-4676&rft.au=COSTAS-INSUA,%20Carlos&HERMOSO-L%C3%93PEZ,%20Alba&MORENO,%20Estefan%C3%ADa&MONTERO-FERN%C3%81NDEZ,%20Carlos&%C3%81LVARO-BL%C3%81ZQUEZ,%20Alicia&rft.genre=article


Archivos en el ítem

Thumbnail
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem